Yeah, commentary over a year old and board revitalized with some serious players since then. Even a small deal validates Bisantrene clinically and commercially in the eyes of industry, which has huge implications for sentiment. It also invalidates the main critique of Bisantrene being an old boring drug.
Happy to be corrected on what you think is the cause for the blackout.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.085(7.14%) |
Mkt cap ! $223.2M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.30 | $1.19 | $135.7K | 108.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1255 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 2000 | 1 |
View Market Depth
| Last trade - 12.51pm 18/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |